Press release
Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026
Increase in the frequent traveling among people is directly proportional to the growth of the motion sickness drug market and so scopolamine market.
Significant growth in the developed, as well as developing countries, was witnessed in the aviation market, and once the COVID-19 pandemic effect diminishes, similar growth is expected in the aviation market. For instance, as per the US Department of Transportation, the US airlines carried around 5.0% more passengers on domestic flights and around 3.1% more passengers on international flights in 2018 as compared to 2017. Around 233.6 million passengers on international flights to and from the US was a record high, exceeding the previous high set in 2017. Air travel growth in Asia-Pacific is expected to remain to continue due to which a significant growth in the scopolamine market is expected in Asia-Pacific during the forecast period. Rising medical tourism in countries such as India, Indonesia, and Thailand is also a major factor contributing to the scopolamine market in the region.
A full report of Scopolamine Market is available at: https://www.omrglobal.com/industry-reports/scopolamine-market
Emerging countries such as China, India, Indonesia, and Vietnam are witnessing significant growth in the market. As per the World Bank, the total air passenger in during the period of 2014 and 2018 has witnessed a growth of 104% in Vietnam from 23 million in 2014 to 47 million in 2018. Similarly, India has witnessed a growth of around 100% as air passenger has increased from 82 million in 2014 to 164 million in 2018. Countries such as UK, Indonesia, UAE, and Saudi Arabia each have recorded an overall growth of more than 20% during the period of 2014-2018. Due to this, the demand for motion sickness drugs will be witnessed in the following countries.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/scopolamine-market
Scopolamine is available in all three forms that are oral, injection, and patches. However, patches are widely accepted for the treatment of nausea and vomiting due to motion sickness. Some of the major players offering scopolamine drugs include Novartis AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Baxter International Inc., Myungmoon Pharm Co. Ltd., Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., Phytex Australia, Fine Chemicals Corp., Perrigo Company plc and others.
Global Scopolamine Market- Segmentation
By Type
• Scopolamine Butyl bromide
• Scopolamine Base
By Dosage Type
• Oral
• Patches
• Injections
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/scopolamine-market
Global Scopolamine Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Alchem International Pvt. Ltd.
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Ltd.
• Caleb Pharmaceuticals, Inc.
• Fine Chemicals Corp.
• Guangzhou Hanfang Pharmaceutical Co., Ltd.
• Myungmoon Pharm Co. Ltd.
• Novartis AG
• Perrigo Co. plc
• Pfizer Inc.
• Phytex Australia
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026 here
News-ID: 2139801 • Views: …
More Releases from Orion Market Research
Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Fo …
In 2024, the global Mobile Gamma Cameras Market was valued at approximately USD 57.8 million, and it is expected to reach USD 79.2 million by 2033, reflecting a compound annual growth rate (CAGR) of around 3.39% between 2025 and 2033.
Mobile Gamma Cameras Market Overview
The Mobile Gamma Cameras Market is seeing steady growth, with demand rising across oncology, cardiology, and nuclear medicine due to its ability to provide portable,…
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare …
In 2024, the global Dental Implants Market was valued at approximately USD 6.8 billion, and it is projected to reach USD 9.8 billion by 2033, representing a compound annual growth rate (CAGR) of around 4.2% from 2025 to 2033.
Dental Implants Market Overview
The Dental Implants Market is experiencing robust growth driven by rising global incidences of tooth loss, heightened demand for aesthetic and permanent dental solutions, and rapid technological advancements-such…
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dic …
In 2024, the global Cell-based Assays Market is estimated at approximately USD 24.1 billion, and it is forecast to reach USD 45.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 6.9% from 2025 to 2033.
Cell-based Assays Market Overview
The Cell-based Assays Market is witnessing sustained growth driven by increased demand from drug discovery, disease modeling, and safety/toxicity testing. These assays-crucial in early-stage pharmaceutical R&D-offer biologically relevant…
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033.
Business Analytics Market Overview
The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,…
More Releases for Scopolamine
Scopolamine Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The scopolamine market is estimated to augment at a CAGR of around 4.5% during the forecast period. Hyoscine is another name of the scopolamine which is majorly used to treat motion sickness & nausea and vomiting. Increasing the patient pool of the people suffering from stress and anxiety disorder due to motion sickness is the major factor for the market augmentation during the forecast period. Motion sickness is an uneasiness…
Scopolamine Market Unveiled: Navigating Trends and Innovations in Antiemetic The …
The Scopolamine market plays a vital role in the pharmaceutical landscape, offering a therapeutic solution rooted in the medicinal properties of the tropane alkaloid derived from plants of the Solanaceae family. Scopolamine, recognized for its antimuscarinic effects, finds application in various medical contexts, most notably in the prevention of nausea and vomiting associated with motion sickness and anesthesia. As a key player in the antiemetic market, Scopolamine has garnered attention…
Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026
The scopolamine market is estimated to augment at a CAGR of around 4.5% during the forecast period. Hyoscine is another name of the scopolamine which is majorly used to treat motion sickness & nausea and vomiting. Increasing the patient pool of the people suffering from stress and anxiety disorder due to motion sickness is the major factor for the market augmentation during the forecast period. Motion sickness is an uneasiness…
Scopolamine Market With Four Main Geographies And Their Countries
This research study on "Scopolamine market" reports offers the comparative assessment of Scopolamine market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This Scopolamine Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions, ranging to that…
Scopolamine Market CAGR, Key Players, Applications, Products and Regions
The Scopolamine market report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. The report also gives insight on entry and exit barriers of the industry.
The Scopolamine market report covers major Manufactures Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin.
Initially report provides information about Scopolamine Market Scenario, Development Prospect,…
Transdermal Scopolamine Market - Positive long-term growth outlook 2024
In this research report, the worldwide market for transdermal scopolamine is primarily analyzed on the basis of its geographical presence. As per the study, Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific are the primary geographical segments of this market. North America, among these, has emerged as key contributor to this market, thanks to the presence of an advanced healthcare industry. Driven by the high…
